HK15695A - Solid oral administration forms containing ifosfamide as active agent - Google Patents

Solid oral administration forms containing ifosfamide as active agent Download PDF

Info

Publication number
HK15695A
HK15695A HK15695A HK15695A HK15695A HK 15695 A HK15695 A HK 15695A HK 15695 A HK15695 A HK 15695A HK 15695 A HK15695 A HK 15695A HK 15695 A HK15695 A HK 15695A
Authority
HK
Hong Kong
Prior art keywords
weight
ifosfamide
parts
tablets
capsules
Prior art date
Application number
HK15695A
Other languages
German (de)
English (en)
French (fr)
Inventor
Dieter Sauerbier
Joergen Dr Engel
Eckhard Dr Milsmann
Klaus Dr Molge
Otto Dr Isaac
Original Assignee
Asta Medica Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Aktiengesellschaft filed Critical Asta Medica Aktiengesellschaft
Publication of HK15695A publication Critical patent/HK15695A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15695A 1990-08-03 1995-02-06 Solid oral administration forms containing ifosfamide as active agent HK15695A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4024683 1990-08-03
SG181694A SG181694G (en) 1990-08-03 1994-12-30 Solid oral administration forms containing ifosfamide as active agent

Publications (1)

Publication Number Publication Date
HK15695A true HK15695A (en) 1995-02-10

Family

ID=25895607

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15695A HK15695A (en) 1990-08-03 1995-02-06 Solid oral administration forms containing ifosfamide as active agent

Country Status (33)

Country Link
US (1) US5158776A (cs)
EP (1) EP0469440B1 (cs)
JP (2) JP3061898B2 (cs)
KR (1) KR0177170B1 (cs)
CN (1) CN1046851C (cs)
AR (1) AR247484A1 (cs)
AT (1) ATE110261T1 (cs)
AU (2) AU643309B2 (cs)
BG (1) BG60900B1 (cs)
CA (1) CA2048367C (cs)
CZ (1) CZ280475B6 (cs)
DE (2) DE4124481A1 (cs)
DK (1) DK0469440T3 (cs)
EG (1) EG19690A (cs)
ES (1) ES2058999T3 (cs)
FI (1) FI97951C (cs)
HK (1) HK15695A (cs)
HR (1) HRP920575B1 (cs)
HU (1) HU206268B (cs)
IE (1) IE66378B1 (cs)
IL (1) IL99031A (cs)
LT (1) LT3528B (cs)
LV (1) LV10043B (cs)
MC (1) MC2274A1 (cs)
MX (1) MX9100441A (cs)
NO (1) NO178252C (cs)
NZ (1) NZ239222A (cs)
PT (1) PT98532B (cs)
RO (1) RO113611B1 (cs)
SG (1) SG181694G (cs)
SI (1) SI9111342B (cs)
SK (2) SK279740B6 (cs)
ZA (1) ZA916124B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0804174A4 (en) * 1993-07-21 1998-09-09 Univ Kentucky Res Found MULTI-CHAMBER HARD CAPSULES WITH CONTROLLED DELIVERY CHARACTERISTICS
ITFI970184A1 (it) * 1997-07-30 1999-01-30 Menarini Farma Ind Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
DE19733305A1 (de) * 1997-08-01 1999-02-04 Asta Medica Ag Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin
US6103297A (en) * 1998-01-14 2000-08-15 Matsushita Electronics Corporation Method of manufacturing cathode-ray tube
DE19826517B4 (de) * 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette
US20040253307A1 (en) * 2003-02-04 2004-12-16 Brian Hague Sugar-free oral transmucosal solid dosage forms and uses thereof
DE102005008797A1 (de) * 2005-02-25 2006-09-07 Baxter International Inc., Deerfield Trofosfamid-haltige Filmtabletten und Verfahren zu deren Herstellung
CN106413706A (zh) * 2014-01-06 2017-02-15 铁治疗控股公司 三麦芽酚铁的剂量方案
GB201418710D0 (en) 2014-10-21 2014-12-03 Iron Therapeutics Holdings Ag Dosage regimen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987204A (en) 1972-09-15 1976-10-19 Sucrest Corporation Direct compression vehicle
JPS5646807A (en) * 1979-09-27 1981-04-28 Japan Atom Energy Res Inst Production of composition of complex gradually releasing physiologically active substance
DE3111428A1 (de) * 1981-03-24 1982-10-07 Asta-Werke Ag, Chemische Fabrik, 4800 Bielefeld Oxazaphosphorin-4-thio-alkansulfonsaeuren und deren neutrale salze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
US4618692A (en) * 1981-09-03 1986-10-21 Asta-Werke Aktiengesellschaft 4-carbamoyloxy-oxazaphosphorins
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
EP0254902B1 (de) * 1986-07-11 1991-08-28 ASTA Pharma Aktiengesellschaft Lösungen von Oxazaphosphorinen mit verbesserter Stabilität und Verfahren zu deren Herstellung
DE3804686A1 (de) * 1988-02-15 1989-08-24 Henkel Kgaa Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten

Also Published As

Publication number Publication date
LV10043A (lv) 1994-05-10
FI913710L (fi) 1992-02-04
JP3061898B2 (ja) 2000-07-10
EP0469440A1 (de) 1992-02-05
SK279740B6 (sk) 1999-03-12
ATE110261T1 (de) 1994-09-15
MC2274A1 (fr) 1993-06-23
ZA916124B (en) 1992-04-29
EG19690A (en) 1995-09-30
BG94934A (bg) 1993-12-24
NO913019D0 (no) 1991-08-02
FI97951B (fi) 1996-12-13
NZ239222A (en) 1993-01-27
IL99031A (en) 1996-09-04
DE59102620D1 (de) 1994-09-29
JP2000229860A (ja) 2000-08-22
IE912774A1 (en) 1992-02-12
SK279739B6 (sk) 1999-03-12
KR920003963A (ko) 1992-03-27
CN1058715A (zh) 1992-02-19
NO178252C (no) 1996-02-21
HUT59316A (en) 1992-05-28
AU4483693A (en) 1993-11-11
SG181694G (en) 1995-05-12
SI9111342A (sl) 1998-04-30
DK0469440T3 (da) 1994-11-14
CA2048367C (en) 2000-05-23
CZ280475B6 (cs) 1996-01-17
CA2048367A1 (en) 1992-02-04
ES2058999T3 (es) 1994-11-01
DE4124481A1 (de) 1992-02-06
NO913019L (no) 1992-02-04
LT3528B (en) 1995-11-27
NO178252B (no) 1995-11-13
KR0177170B1 (ko) 1999-03-20
JP3545300B2 (ja) 2004-07-21
CS240991A3 (en) 1992-03-18
PT98532A (pt) 1992-06-30
JPH04243828A (ja) 1992-08-31
IL99031A0 (en) 1992-07-15
RO113611B1 (ro) 1998-09-30
AR247484A1 (es) 1995-01-31
PT98532B (pt) 1999-01-29
HRP920575B1 (en) 1999-04-30
SI9111342B (sl) 1998-10-31
AU8158991A (en) 1992-02-06
MX9100441A (es) 1992-04-01
BG60900B1 (bg) 1996-06-28
LTIP921A (en) 1995-03-27
FI913710A0 (fi) 1991-08-02
HRP920575A2 (en) 1995-04-30
CN1046851C (zh) 1999-12-01
AU649184B2 (en) 1994-05-12
US5158776A (en) 1992-10-27
HU912594D0 (en) 1992-01-28
AU643309B2 (en) 1993-11-11
FI97951C (fi) 1997-03-25
HU206268B (en) 1992-10-28
EP0469440B1 (de) 1994-08-24
LV10043B (en) 1995-06-20
IE66378B1 (en) 1995-12-27

Similar Documents

Publication Publication Date Title
US3773920A (en) Sustained release medicinal composition
US4834985A (en) Controlled release pharmaceutical composition
KR100322340B1 (ko) 경구 콜레스테롤 저하제
US4925675A (en) Erythromycin microencapsulated granules
IE55190B1 (en) Extended action controlled release compositions
HK15695A (en) Solid oral administration forms containing ifosfamide as active agent
DE69907258T2 (de) Verfahren zur herstellung von dinatriumpamidronat
NZ200244A (en) Gallopamil or verapamil as calcium-antagonistic active compounds in sustained release pharmaceutical compositions
US4491575A (en) Compressed products with retarded release of active substance, a process for their preparation and a process for the long-term administration of medicaments
IE883032L (en) Pharmaceutical compositions comprising a piperidinoalkanol
EP0266707B1 (en) Sustained release labetalol tablet
JP3552285B2 (ja) 経口コレステロール低下剤
RU2039553C1 (ru) Твердая лекарственная форма ифосфамида
US3100738A (en) Uniform release process
EP1233758A2 (de) Natriumvalproat-granulat mit verringerter hygroskopizität
DE68908320T2 (de) Enterische Beschichtung und ihre Herstellung.
TR2023015500A1 (tr) Bri̇varasetam i̇çeren deği̇şti̇ri̇lmi̇ş salimli bi̇r tablet kompozi̇syonu
JPH0413627A (ja) 経口コレステロール低下剤
EP1896021A1 (de) Feste pharmazeutische zubereitung enthaltend (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chroman
JPS61152629A (ja) 徐放性テオフィリン調剤及びその製法

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100724